These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 792579)

  • 1. The use of procarbazine hydrochloride versus cyclophosphamide in donor pretreatment in cadaveric renal transplantation.
    Zincke H; Woods JE; Roses J; Kimbler RW
    Mayo Clin Proc; 1976 Nov; 51(11):693-6. PubMed ID: 792579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor pretreatment in an unselected series of cadaver renal allografts.
    Guttmann RD; Morehouse DD; Meakins JL; Klassen J; Knaack J; Beaudoin JG
    Kidney Int Suppl; 1978 Jun; (8):S99-102. PubMed ID: 357821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor pretreatment in cadaver renal transplantation.
    Zincke H; Woods JE
    Surg Gynecol Obstet; 1977 Aug; 145(2):183-8. PubMed ID: 327596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid-cyclophosphamide pretreatment of kidney allograft donors. A control study.
    Soulillou JP; Baron D; Rouxel A; Guenel J
    Nephron; 1979; 24(4):193-7. PubMed ID: 386157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on the mechanism of donor pretreatment: effect of procarbazine hydrochloride and methylprednisolone in immunocompetent cells.
    van der Linden CJ; Buurman WA; Vegt PA; Greep JM; Jeekel J
    Transplantation; 1981 Jul; 32(1):24-8. PubMed ID: 7022795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological donor pretreatment in combination with pulsatile preservation in cadaveric renal transplantation.
    Zincke H; Woods JE; Khan AU; Holley KE; Leary FJ
    Transplantation; 1978 Oct; 26(4):207-11. PubMed ID: 360522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment of cadaver donors with cyclophosphamide and methylprednisolone: effect on renal transplant outcome.
    Corry RJ; Patel NP; West JC; Schanbacher BA
    Transplant Proc; 1980 Jun; 12(2):348-51. PubMed ID: 6994305
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized prospective study of cadaver donor pretreatment in renal transplantation.
    Jeffery JR; Downs A; Grahame JW; Lye C; Ramsey E; Thomson AE
    Transplantation; 1978 Jun; 25(6):287-9. PubMed ID: 351886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attempted immunological alteration of canine renal allograft donors.
    Zincke H; Woods JE
    Transplantation; 1974 Dec; 18(6):480-6. PubMed ID: 4612885
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal donor pretreatment with cytotoxic agents: immunologically ineffective and damaging to the graft.
    Burleson RL; Jones DB; Yenikomshian A; DeVoe C; DeRito J
    Transplant Proc; 1977 Sep; 9(3):1591-6. PubMed ID: 331594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro monitoring of cadaver kidney donor pretreatment by lymphocyte culture.
    Jeffery JR; Guttmann RD; Charpentier B
    Clin Exp Immunol; 1976 Sep; 25(3):437-41. PubMed ID: 134860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment of cadaver donors with methylprednisolone in human renal allografts.
    Chatterjee SN; Terasaki PI; Fine S; Schulman B; Smith R; Fine RN
    Surg Gynecol Obstet; 1977 Nov; 145(5):729-32. PubMed ID: 333644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolongation of canine renal allograft survival. A study on the effect of donor pretreatment.
    van der Linden CJ; Buurman WA; Vegt PA; Greep JM; Jeekel J
    Transplantation; 1980 Aug; 30(2):132-4. PubMed ID: 7010708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of donor pretreatment prolongs canine renal allograft survival.
    Dienst SG; MacDonald R; Toledo-Pereyra LH; Fox B
    Transplant Proc; 1979 Jun; 11(2):1465-6. PubMed ID: 382541
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
    Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
    Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of high doses of intravenous methylprednisolone and cyclophosphamide on renal homografts.
    Zincke H; Woods JE; Holley KE
    Urology; 1977 Oct; 10(4):301-4. PubMed ID: 335605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing outcome of kidney allografts from pretreated cadaveric donors.
    Sterioff S; Zincke H; Waltzer WC; Moore SB; Frohnert PP; Offord KP
    Arch Surg; 1981 Jan; 116(1):73-7. PubMed ID: 7008743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression and rehabilitation following cadaveric renal transplantation. New developments.
    Guttmann RD; Beaudoin JG; Gonda A; Gorman P
    Urology; 1973 Feb; 1(2):102-7. PubMed ID: 4589225
    [No Abstract]   [Full Text] [Related]  

  • 19. Manipulation of allograft immunogenicity by pretreatment of cadaver donors.
    Guttmann RD
    Urol Clin North Am; 1976 Oct; 3(3):475-90. PubMed ID: 790729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing ways of reducing allograft immunogenicity.
    Guttmann RD
    Can Med Assoc J; 1981 Jan; 124(2):143-5. PubMed ID: 7006782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.